Skip to main content

Market Overview

Mid-Morning Market Update: Markets Open Higher; Kroger Posts Mixed Q2 Results

Share:

Following the market opening Thursday, the Dow traded up 0.37% to 27236.49 while the NASDAQ rose 0.74% to 8229.82. The S&P also rose, gaining 0.47% to 3015.02.

Leading and Lagging Sectors

Information technology shares climbed 1.1% on Thursday. Meanwhile, top gainers in the sector included Cambium Networks Corporation (NASDAQ: CMBM), up 5%, and International Money Express, Inc. (NASDAQ: IMXI), up 6%.

In trading on Thursday, energy shares fell 0.5%.

Top Headline

Kroger Co (NYSE: KR) reported better-than-expected earnings for its second quarter, while sales missed views.

Second-quarter earnings came in at 44 cents per share, beating estimates of 41 cents. Sales came in at $28.17 billion, versus estimates by $28.38 billion.

Kroger plans to continue to reduce costs and says it is on track to deliver $100 million in incremental operating profit through alternative profit stream growth. Kroger maintained its 2019 outlook.

Equities Trading UP

Sintx Technologies, Inc. (NASDAQ: SINT) shares shot up 96% to $2.94 after Ascendiant Capital initiated coverage on the stock with a Buy rating and a $3 price target.

Shares of MDJM Ltd. (NASDAQ: MDJH) got a boost, shooting up 17% to $3.06 after the company reported results for the first six month of fiscal year 2019.

Moderna, Inc. (NASDAQ: MRNA) shares were also up, gaining 16% to $18.39 after the company reported positive results on its Phase 1 CMV Vaccine study and is moving forward to its mRNA-1647 dose confirmation Phase 2.

Equities Trading DOWN

Tocagen Inc. (NASDAQ: TOCA) shares tumbled 79% to $0.8901 following an adverse clinical trial readout. Tocagen, a thinly traded nano-cap biotech, said Thursday morning a Phase 3 TOCA 5 study evaluating Toca 511 and Toca FC in patients with recurrent, high-grade glioma undergoing resection missed the primary endpoint of overall survival compared to the standard of care.

Shares of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) were down 26% to $8.91 after the company reported data from the first cohort of OPTIC phase 1 trial of ADVM-022 intravitreal gene therapy to treat wet AMD.

Tailored Brands, Inc. (NYSE: TLRD) was down, falling 24% to $5.46 after the company issued Q3 EPS guidance below analyst estimates. The company also suspended its quarterly dividend.

Commodities

In commodity news, oil traded down 0.9% to $55.26, while gold traded up 0.6% to $1,511.70.

Silver traded up 0.7% Thursday to $18.295, while copper rose 1.6% to $2.6575.

Euro zone

European shares were mixed today. The eurozone’s STOXX 600 fell 0.1%, the Spanish Ibex Index fell 0.2%, while Italy’s FTSE MIB Index rose 0.1%. Meanwhile, the German DAX rose 0.1% and the French CAC 40 slipped 0.1% while UK shares rose 0.1%.

Economics

The Consumer Price Index rose 0.1% for August, versus economists’ expectations for a 0.1% increase.

U.S. initial jobless claims fell 15,000 to 204,000 for the latest week. However, analysts were expecting a 215,000 reading.

The Energy Information Administration’s weekly report on Initial jobless claims is schedule for release at 10:30 a.m. ET.

The Treasury is set to auction 4-and 8-week bills at 11:30 a.m. ET.

The U.S. Treasury budget report for August will be released at 2:00 p.m. ET.

Data on money supply for the recent week will be released at 4:30 p.m. ET.

 

Related Articles (ADVM + CMBM)

View Comments and Join the Discussion!

Posted-In: Mid-Morning Market UpdateEarnings News Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com